Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CCNE1 inhibitors(Cyclin E1 inhibitors), CDK2 inhibitors(Cyclin-dependent kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Cedilla Therapeutics, Inc.Startup |
Active Organization |
Inactive Organization Cedilla Therapeutics, Inc.Startup |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | US | Cedilla Therapeutics, Inc.Startup | 01 Jun 2023 |
Neoplasms | Preclinical | US | 01 Jun 2023 |